Table of Content



Chapter 1 Report Scope and Objectives
1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 GVR’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.2.5 Details of Primary Research
2.3 Information or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis
2.6 List of Secondary Sources
2.7 List of Abbreviations
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Business Model
3.2.2 End - use
3.3Competitive Insights
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage outlook
4.1.1 Parent market outlook
4.1.2 Ancillary/related market outlook
4.2 Market Dynamics
4.2.1 Market driver analysis
4.2.1.1 Vertical integration of key market players
4.2.1.2 Introduction of improved health benefit plans
4.2.1.3 Growing prevalence of chronic diseases in the U.S.
4.2.2 Market restraint analysis
4.2.2.1 Stringent regulations to cut back rebates
4.3 Penetration & Growth Prospect Mapping
4.4 Business Environment Analysis Tools
4.4.1 Porter’s Five Forces analysis
4.4.1.1 Competitive rivalry
4.4.1.2 Threat of new entrants
4.4.1.3 Bargaining power of buyers
4.4.1.4 Bargaining power of suppliers
4.4.1.5 Threat of substitutes
4.4.2 PESTEL Analysis
4.4.2.1 Political landscape
4.4.2.2 Economic and social landscape
4.4.2.3 Technological landscape
4.3 Impact of COVID - 19: Qualitative Analysis
Chapter 5 U.S. Pharmacy Benefit Management Market: Business Model Analysis
5.1 U.S. Pharmacy Benefit Management Business Model Market Share Analysis, 2022 & 2030
5.2 U.S. Pharmacy Benefit Management Business Model Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Business Model Segment
5.3.1 Standalone PBM
5.3.1.1 Standalone PBM market, 2017 - 2030 (USD Billion)
5.3.2 Health Insurance Providers
5.3.2.1 Health insurance providers market, 2017 - 2030 (USD Billion)
5.3.3 Retail Pharmacy
5.3.3.1 Retail pharmacy market, 2017 - 2030 (USD Billion)
Chapter 6 U.S. Pharmacy Benefit Management Market: End - use Analysis
6.1 U.S. Pharmacy Benefit Management End - use Market Share Analysis, 2022 & 2030
6.2 U.S. Pharmacy Benefit Management End - use Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End - use Segment
6.3.1 Commercial
6.3.1.1 Commercial market, 2017 - 2030 (USD Billion)
6.3.2 Federal
6.3.2.1 Federal market, 2017 - 2030 (USD Billion)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Competition Categorization (Key innovators, Market leaders, Emerging Players
7.3 Company Market Position Analysis
7.4 Company Profiles
7.4.1 CVS HEALTH
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Service benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Elixir Rx Solutions LLC
7.4.2.1 Company overview
7.4.2.2 Service benchmarking
7.4.2.3 Strategic initiatives
7.4.3 Optum, Inc
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.2 Service benchmarking
7.4.3.3 Strategic initiatives
7.4.4 Cigna
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.2 Service benchmarking
7.4.4.3 Strategic initiatives
7.4.5 Change Healthcare
7.4.5.1 Company overview
7.4.5.2 Service benchmarking
7.4.5.3 Strategic initiatives
7.4.6 MedImpact
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Service benchmarking
7.4.6.4 Strategic initiatives
7.4.7 Prime Therapeutics LLC
7.4.7.1 Company overview
7.4.7.2 Service benchmarking
7.4.7.3 Strategic initiatives
7.4.8 HUB International Limited.
7.4.8.1 Company overview
7.4.8.2 Service benchmarking
7.4.8.3 Strategic initiatives
7.4.9 Anthem
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Service benchmarking
7.4.9.4 Strategic initiatives??



List of Figures

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market outlook
FIG. 9 Pharmacy benefit management market segmentation
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 U.S. pharmacy benefit management business model market share analysis, 2022 & 2030
FIG. 15 U.S. pharmacy benefit management business model market: Segment dashboard
FIG. 16 Standalone PBM market, 2017 - 2030 (USD Billion)
FIG. 17 Health insurance providers market, 2017 - 2030 (USD Billion)
FIG. 18 Retail pharmacy market, 2017- 2030 (USD Billion)
FIG. 19 U.S. pharmacy benefit management market end-use movement analysis, 2022 & 2030
FIG. 20 U.S. pharmacy benefit management end-use market: Segment dashboard
FIG. 21 Commercial market, 2017 - 2030 (USD Billion)
FIG. 22 Federal market, 2017- 2030 (USD Billion)
FIG. 23 Recent developments & impact analysis, by key market participants
FIG. 24 Strategy framework
FIG. 25 Competition Categorization
FIG. 26 Company market position analysis

List of Tables

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 U.S. U.S. pharmacy benefit management market, by business model, 2017 - 2030 (USD Billion)
TABLE 4 U.S. U.S. pharmacy benefit management market, by end-use, 2017 - 2030 (USD Billion)